Astera Labs (ALAB) Financials

$215.69 +14.44 (+7.18%)

Closing price 05/5/2026 04:00 PM Eastern

Extended Trading

$231.50 +15.81 (+7.33%)

As of 05:23 AM Eastern

Annual Income Statements for Astera Labs

This table shows Astera Labs' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024	2025
Period end date	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	-58	-26	-83	219
Consolidated Net Income / (Loss)	-58	-26	-83	219
Net Income / (Loss) Continuing Operations	-58	-26	-83	219
Total Pre-Tax Income	-58	-23	-82	218
Total Operating Income	-60	-29	-116	173
Total Gross Profit	59	80	303	645
Total Revenue	80	116	396	853
Operating Revenue	80	116	396	853
Total Cost of Revenue	21	36	94	207
Operating Cost of Revenue	21	36	94	207
Total Operating Expenses	119	109	419	472
Selling, General & Admin Expense	21	16	94	88
Marketing Expense	24	20	124	80
Research & Development Expense	74	73	201	304
Total Other Income / (Expense), net	2.61	6.55	34	45
Interest & Investment Income	2.61	6.55	34	45
Income Tax Expense	0.76	3.31	1.64	-0.98
Basic Earnings per Share	($1.71)	($0.71)	($0.64)	$1.32
Weighted Average Basic Shares Outstanding	34.17M	37.13M	131.26M	166.41M
Diluted Earnings per Share	($1.71)	($0.71)	($0.64)	$1.22
Weighted Average Diluted Shares Outstanding	34.17M	37.13M	131.26M	179.55M
Weighted Average Basic & Diluted Shares Outstanding	-	-	162.15M	170.21M

This table shows Astera Labs' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025
Period end date	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	-20	-3.12	14	-93	-7.55	-7.59	25	32	51	91	45
Consolidated Net Income / (Loss)	-20	-3.12	14	-93	-7.55	-7.59	25	32	51	91	45
Net Income / (Loss) Continuing Operations	-20	-3.12	14	-93	-7.55	-7.59	25	32	51	91	45
Total Pre-Tax Income	-16	-0.25	11	-80	-14	2.02	11	22	51	67	79
Total Operating Income	-18	-1.98	9.02	-83	-24	-8.90	0.14	11	40	55	67
Total Gross Profit	8.44	28	39	51	60	88	104	119	146	176	204
Total Revenue	11	37	51	65	77	113	141	159	192	231	271
Operating Revenue	11	37	51	65	77	113	141	159	192	231	271
Total Cost of Revenue	2.25	8.82	11	15	17	25	37	40	46	55	66
Operating Cost of Revenue	2.25	8.82	11	15	17	25	37	40	46	55	66
Total Operating Expenses	26	30	30	133	84	97	104	108	106	120	138
Selling, General & Admin Expense	3.10	3.95	5.36	24	22	23	25	22	20	22	24
Marketing Expense	5.10	5.51	5.00	56	22	23	23	22	19	19	20
Research & Development Expense	18	21	20	54	40	51	57	65	67	79	94
Total Other Income / (Expense), net	1.56	1.72	1.67	2.55	10	11	11	10	11	11	12
Interest & Investment Income	1.56	1.72	1.67	2.55	10	11	11	10	11	11	12
Income Tax Expense	3.95	2.87	-3.63	13	-6.54	9.61	-14	-10	-0.56	-24	34
Basic Earnings per Share	($0.55)	($0.08)	$0.41	($1.77)	($0.05)	($0.05)	$1.23	$0.19	$0.31	$0.54	$0.28
Weighted Average Basic Shares Outstanding	36.57M	37.47M	37.13M	52.53M	155.20M	156.83M	131.26M	163.19M	165.43M	167.44M	166.41M
Diluted Earnings per Share	($0.55)	($0.08)	$0.41	($1.77)	($0.05)	($0.05)	$1.23	$0.18	$0.29	$0.50	$0.25
Weighted Average Diluted Shares Outstanding	36.57M	37.47M	37.13M	52.53M	155.20M	156.83M	131.26M	178.12M	178.10M	180.63M	179.55M
Weighted Average Basic & Diluted Shares Outstanding	-	-	0.00	155.70M	156.66M	158.61M	162.15M	164.92M	166.22M	168.90M	170.21M

This table details how cash moves in and out of Astera Labs' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024	2025
Period end date	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	25	-31	35	88
Net Cash From Operating Activities	-36	-13	137	319
Net Cash From Continuing Operating Activities	-36	-13	137	319
Net Income / (Loss) Continuing Operations	-58	-26	-83	219
Consolidated Net Income / (Loss)	-58	-26	-83	219
Depreciation Expense	0.81	1.78	3.15	6.83
Amortization Expense	-0.53	-1.66	-8.44	-7.93
Non-Cash Adjustments To Reconcile Net Income	32	23	239	167
Changes in Operating Assets and Liabilities, net	-9.97	-9.68	-13	-66
Net Cash From Investing Activities	-91	-18	-758	-241
Net Cash From Continuing Investing Activities	-91	-18	-758	-241
Purchase of Property, Plant & Equipment	-3.87	-2.76	-34	-38
Acquisitions	-	0.00	0.00	-29
Purchase of Investments	-89	-126	-931	-858
Sale and/or Maturity of Investments	2.00	111	209	683
Other Investing Activities, net	0.00	0.00	-1.41	-0.50
Net Cash From Financing Activities	152	-0.50	656	9.80
Net Cash From Continuing Financing Activities	152	-0.50	656	9.80
Repurchase of Common Equity	-0.31	-1.62	-5.87	0.00
Issuance of Common Equity	0.00	0.00	676	7.98
Other Financing Activities, net	2.12	1.12	-15	1.83

This table details how cash moves in and out of Astera Labs' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025
Period end date	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025
Net Change in Cash & Equivalents	-14	-56	7.38	651	-275	-295	-46	6.95	76	-22	26
Net Cash From Operating Activities	-23	-0.33	14	3.65	30	64	40	11	135	78	95
Net Cash From Continuing Operating Activities	-23	-0.33	14	3.65	30	64	40	11	135	78	95
Net Income / (Loss) Continuing Operations	-20	-3.12	14	-93	-7.55	-7.59	25	32	51	91	45
Consolidated Net Income / (Loss)	-20	-3.12	14	-93	-7.55	-7.59	25	32	51	91	45
Depreciation Expense	0.41	0.48	0.54	0.61	0.72	0.85	0.97	1.13	1.39	1.47	2.85
Amortization Expense	-0.23	-0.40	-0.59	-0.57	-1.07	-3.23	-3.47	-2.54	-1.95	-1.79	-1.65
Non-Cash Adjustments To Reconcile Net Income	3.06	3.81	4.18	99	45	46	49	42	40	43	42
Changes in Operating Assets and Liabilities, net	-6.20	-1.10	-4.06	-2.23	-7.77	27	-31	-62	45	-56	7.05
Net Cash From Investing Activities	9.16	-56	-5.96	-4.25	-302	-359	-91	-3.94	-64	-101	-73
Net Cash From Continuing Investing Activities	9.16	-56	-5.96	-4.25	-302	-359	-91	-3.94	-64	-101	-73
Purchase of Property, Plant & Equipment	-0.58	-0.74	-1.01	-3.42	1.32	-17	-15	-4.54	-2.02	-12	-19
Purchase of Investments	-4.93	-76	-23	-23	-322	-379	-206	-191	-214	-260	-193
Sale and/or Maturity of Investments	15	20	18	22	19	36	131	191	152	171	168
Net Cash From Financing Activities	-0.12	0.64	-1.06	652	-2.34	0.95	5.65	0.39	4.74	0.95	3.73
Net Cash From Continuing Financing Activities	-0.12	0.64	-1.06	652	-2.34	0.95	5.65	0.39	4.74	0.95	3.73
Issuance of Common Equity	-	-	-	672	-	-	4.16	0.00	4.35	-	3.63
Other Financing Activities, net	-0.03	0.66	0.45	-19	0.70	0.95	2.56	0.39	0.39	0.95	0.10

This table presents Astera Labs' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2023	2024	2025
Period end date	12/31/2023	12/31/2024	12/31/2025
Total Assets	196	1,055	1,532
Total Current Assets	186	1,013	1,362
Cash & Equivalents	45	80	168
Short-Term Investments	104	835	1,021
Accounts Receivable	8.34	39	83
Inventories, net	24	43	59
Prepaid Expenses	4.06	17	31
Plant, Property, & Equipment, net	4.71	36	92
Total Noncurrent Assets	5.77	5.88	78
Other Noncurrent Operating Assets	5.77	5.88	78
Total Liabilities & Shareholders' Equity	196	1,055	1,532
Total Liabilities	39	90	168
Total Current Liabilities	35	87	133
Accounts Payable	6.34	27	42
Accrued Expenses	29	60	91
Total Noncurrent Liabilities	3.79	3.17	35
Other Noncurrent Operating Liabilities	3.79	3.17	35
Commitments & Contingencies	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	-98	965	1,364
Total Preferred & Common Equity	-98	965	1,364
Total Common Equity	-98	965	1,364
Common Stock	27	1,173	1,349
Retained Earnings	-125	-209	10
Accumulated Other Comprehensive Income / (Loss)	0.26	0.43	4.31

This table presents Astera Labs' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025
Period end date	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025
Total Assets	865	916	983	1,122	1,271	1,401
Total Current Assets	854	891	946	1,076	1,181	1,290
Cash & Equivalents	696	421	126	86	162	140
Short-Term Investments	105	410	761	838	903	994
Accounts Receivable	17	22	25	70	24	43
Inventories, net	30	29	24	51	59	52
Prepaid Expenses	6.73	9.45	8.99	30	33	61
Plant, Property, & Equipment, net	7.58	22	35	39	62	72
Total Noncurrent Assets	2.88	2.45	2.34	6.40	29	39
Other Noncurrent Operating Assets	2.88	2.45	2.34	6.40	29	39
Total Liabilities & Shareholders' Equity	865	916	983	1,122	1,271	1,401
Total Liabilities	56	70	93	80	136	129
Total Current Liabilities	46	64	88	77	106	101
Accounts Payable	11	15	19	30	32	26
Accrued Expenses	34	49	69	48	75	75
Total Noncurrent Liabilities	11	6.19	5.41	2.85	29	28
Other Noncurrent Operating Liabilities	11	6.19	5.41	2.85	29	28
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	809	845	890	1,042	1,136	1,272
Total Preferred & Common Equity	809	845	890	1,042	1,136	1,272
Total Common Equity	809	845	890	1,042	1,136	1,272
Common Stock	1,027	1,072	1,119	1,217	1,259	1,302
Retained Earnings	-218	-226	-234	-177	-126	-35
Accumulated Other Comprehensive Income / (Loss)	-0.06	-0.35	4.43	2.03	2.87	4.10

This table displays calculated financial ratios and metrics derived from Astera Labs' official financial filings.

Metric	2022	2023	2024	2025
Period end date	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Growth Metrics	-	-	-	-
Revenue Growth	0.00%	44.97%	242.24%	115.13%
EBITDA Growth	0.00%	51.03%	-313.27%	242.00%
EBIT Growth	0.00%	51.00%	-293.48%	249.42%
NOPAT Growth	0.00%	51.00%	-293.48%	314.41%
Net Income Growth	0.00%	55.00%	-217.71%	362.68%
EPS Growth	0.00%	58.48%	9.86%	290.63%
Operating Cash Flow Growth	0.00%	64.58%	1,174.83%	133.62%
Free Cash Flow Firm Growth	0.00%	0.00%	-329.86%	140.35%
Invested Capital Growth	0.00%	0.00%	522.43%	246.19%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	17.91%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%	69.14%
EBIT Q/Q Growth	0.00%	0.00%	0.00%	62.67%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%	23.20%
Net Income Q/Q Growth	0.00%	0.00%	0.00%	10.19%
EPS Q/Q Growth	0.00%	0.00%	0.00%	-44.55%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	0.00%	21.07%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	622.60%
Invested Capital Q/Q Growth	0.00%	0.00%	1,696.44%	27.32%
Profitability Metrics	-	-	-	-
Gross Margin	73.47%	68.94%	76.38%	75.69%
EBITDA Margin	-75.01%	-25.34%	-30.60%	20.21%
Operating Margin	-75.36%	-25.47%	-29.29%	20.34%
EBIT Margin	-75.36%	-25.47%	-29.29%	20.34%
Profit (Net Income) Margin	-73.05%	-22.68%	-21.05%	25.70%
Tax Burden Percent	101.33%	114.42%	102.01%	100.45%
Interest Burden Percent	95.66%	77.80%	70.46%	125.79%
Effective Tax Rate	0.00%	0.00%	0.00%	-0.45%
Return on Invested Capital (ROIC)	0.00%	-509.01%	-277.24%	154.63%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	-501.49%	-276.83%	150.36%
Return on Net Nonoperating Assets (RNNOA)	0.00%	475.65%	262.37%	-135.81%
Return on Equity (ROE)	0.00%	-33.36%	-14.87%	18.82%
Cash Return on Invested Capital (CROIC)	0.00%	-709.01%	-421.87%	44.28%
Operating Return on Assets (OROA)	0.00%	-15.03%	-18.56%	13.41%
Return on Assets (ROA)	0.00%	-13.38%	-13.34%	16.95%
Return on Common Equity (ROCE)	0.00%	20.70%	-11.49%	18.82%
Return on Equity Simple (ROE_SIMPLE)	0.00%	26.87%	-8.65%	0.00%
Net Operating Profit after Tax (NOPAT)	-42	-21	-81	174
NOPAT Margin	-52.75%	-17.83%	-20.50%	20.43%
Net Nonoperating Expense Percent (NNEP)	0.00%	-7.51%	-0.41%	4.27%
Return On Investment Capital (ROIC_SIMPLE)	-	21.13%	-8.42%	12.77%
Cost of Revenue to Revenue	26.53%	31.06%	23.62%	24.31%
SG&A Expenses to Revenue	25.99%	13.75%	23.79%	10.33%
R&D to Revenue	92.29%	63.39%	50.68%	35.66%
Operating Expenses to Revenue	148.83%	94.41%	105.67%	55.35%
Earnings before Interest and Taxes (EBIT)	-60	-29	-116	173
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-60	-29	-121	172
Valuation Ratios	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	21.77	20.61
Price to Tangible Book Value (P/TBV)	0.00	0.00	21.77	20.61
Price to Revenue (P/Rev)	8.92	6.16	53.01	32.96
Price to Earnings (P/E)	0.00	0.00	0.00	128.23
Dividend Yield	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.78%
Enterprise Value to Invested Capital (EV/IC)	0.00	100.90	397.91	153.93
Enterprise Value to Revenue (EV/Rev)	0.00	7.07	50.70	31.57
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	156.16
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	155.17
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	154.48
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	147.02	84.28
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	539.46
Leverage & Solvency	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00
Financial Leverage	0.00	-0.95	-0.95	-0.90
Leverage Ratio	0.00	1.25	1.11	1.11
Compound Leverage Factor	0.00	0.97	0.79	1.40
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	162.06%	0.00%	0.00%
Common Equity to Total Capital	0.00%	-62.06%	100.00%	100.00%
Debt to EBITDA	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00
Altman Z-Score	0.00	11.13	141.30	102.14
Noncontrolling Interest Sharing Ratio	0.00%	162.06%	22.73%	0.00%
Liquidity Ratios	-	-	-	-
Current Ratio	0.00	5.30	11.71	10.24
Quick Ratio	0.00	4.49	11.01	9.56
Cash Flow Metrics	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-29	-124	50
Operating Cash Flow to CapEx	-926.88%	-460.56%	399.11%	850.48%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-
Asset Turnover	0.00	0.59	0.63	0.66
Accounts Receivable Turnover	0.00	13.89	16.81	13.97
Inventory Turnover	0.00	1.49	2.78	4.06
Fixed Asset Turnover	0.00	24.57	19.64	13.35
Accounts Payable Turnover	0.00	5.68	5.63	5.98
Days Sales Outstanding (DSO)	0.00	26.27	21.71	26.12
Days Inventory Outstanding (DIO)	0.00	244.52	131.25	89.98
Days Payable Outstanding (DPO)	0.00	64.31	64.85	61.00
Cash Conversion Cycle (CCC)	0.00	206.48	88.12	55.10
Capital & Investment Metrics	-	-	-	-
Invested Capital	0.00	8.11	50	175
Invested Capital Turnover	0.00	28.55	13.52	7.57
Increase / (Decrease) in Invested Capital	0.00	8.11	42	124
Enterprise Value (EV)	0.00	819	20,094	26,910
Market Capitalization	713	713	21,008	28,099
Book Value per Share	$0.00	($2.63)	$6.08	$8.07
Tangible Book Value per Share	$0.00	($2.63)	$6.08	$8.07
Total Capital	0.00	157	965	1,364
Total Debt	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00
Net Debt	0.00	-149	-914	-1,189
Capital Expenditures (CapEx)	3.87	2.76	34	38
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	1.42	12	40
Debt-free Net Working Capital (DFNWC)	0.00	151	926	1,229
Net Working Capital (NWC)	0.00	151	926	1,229
Net Nonoperating Expense (NNE)	16	5.61	2.17	-45
Net Nonoperating Obligations (NNO)	0.00	-149	-914	-1,189
Total Depreciation and Amortization (D&A)	0.28	0.16	-5.19	-1.10
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	1.22%	3.06%	4.71%
Debt-free Net Working Capital to Revenue	0.00%	130.17%	233.78%	144.16%
Net Working Capital to Revenue	0.00%	130.17%	233.78%	144.16%
Earnings Adjustments	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	($0.64)	$1.32
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	131.26M	166.41M
Adjusted Diluted Earnings per Share	$0.00	$0.00	($0.64)	$1.22
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	131.26M	179.55M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	162.15M	170.21M
Normalized Net Operating Profit after Tax (NOPAT)	-42	-21	-81	121
Normalized NOPAT Margin	-52.75%	-17.83%	-20.50%	14.24%
Pre Tax Income Margin	-72.09%	-19.82%	-20.64%	25.59%
Debt Service Ratios	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	-0.54%	-6.16%	-7.03%	0.00%

This table displays calculated financial ratios and metrics derived from Astera Labs' official financial filings.

Metric	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025
Period end date	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	0.00%	0.00%	269.44%	619.03%	206.23%	179.32%	144.33%	149.74%	103.89%	91.77%
EBITDA Growth	0.00%	0.00%	0.00%	-336.85%	-41.67%	-494.20%	-126.24%	111.90%	258.58%	587.12%	2,955.05%
EBIT Growth	0.00%	0.00%	0.00%	-338.35%	-38.23%	-349.97%	-98.40%	113.60%	263.36%	722.82%	46,398.61%
NOPAT Growth	0.00%	0.00%	0.00%	-338.35%	-38.23%	2,521.10%	-97.25%	128.47%	335.96%	125.34%	11,377.80%
Net Income Growth	0.00%	0.00%	0.00%	-432.80%	62.28%	-143.05%	72.52%	134.22%	778.76%	1,299.97%	82.02%
EPS Growth	0.00%	0.00%	0.00%	-261.22%	90.91%	37.50%	200.00%	110.17%	680.00%	1,100.00%	-79.67%
Operating Cash Flow Growth	0.00%	0.00%	0.00%	195.63%	229.84%	19,114.37%	175.73%	187.62%	354.05%	23.09%	139.94%
Free Cash Flow Firm Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-41.91%	48.38%	-292.18%	-104.87%
Invested Capital Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	522.43%	1,480.36%	395.39%	4,784.49%	246.19%
Revenue Q/Q Growth	-39.49%	245.51%	36.79%	0.00%	17.76%	47.15%	24.77%	13.00%	20.37%	20.14%	17.35%
EBITDA Q/Q Growth	8.14%	89.11%	572.87%	0.00%	70.21%	54.34%	79.12%	519.02%	297.44%	40.45%	23.72%
EBIT Q/Q Growth	6.94%	88.78%	556.25%	0.00%	70.65%	63.46%	101.62%	7,736.81%	252.45%	39.30%	20.85%
NOPAT Q/Q Growth	6.94%	88.78%	973.08%	0.00%	70.65%	296.60%	-99.01%	4,872.39%	143.21%	87.75%	-49.45%
Net Income Q/Q Growth	-14.61%	84.38%	558.55%	0.00%	91.89%	-0.62%	425.47%	28.75%	60.97%	77.89%	-50.63%
EPS Q/Q Growth	-12.24%	85.45%	612.50%	0.00%	97.18%	0.00%	2,560.00%	-85.37%	61.11%	72.41%	-50.00%
Operating Cash Flow Q/Q Growth	-501.26%	98.55%	4,411.08%	0.00%	716.35%	113.02%	-37.48%	-73.54%	1,188.71%	-42.25%	21.87%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%	52.19%	198.07%	-237.00%	-120.93%	82.61%	-265.09%	-46.05%
Invested Capital Q/Q Growth	0.00%	0.00%	0.00%	0.00%	92.84%	-80.28%	1,696.44%	131.37%	-39.55%	94.40%	27.32%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	78.96%	76.11%	77.26%	77.42%	77.88%	77.71%	74.03%	74.89%	75.84%	76.25%	75.57%
EBITDA Margin	-163.14%	-5.14%	17.77%	-127.06%	-32.14%	-9.97%	-1.67%	6.19%	20.43%	23.89%	25.19%
Operating Margin	-164.79%	-5.35%	17.86%	-127.14%	-31.68%	-7.87%	0.10%	7.08%	20.72%	24.03%	24.75%
EBIT Margin	-164.79%	-5.35%	17.86%	-127.14%	-31.68%	-7.87%	0.10%	7.08%	20.72%	24.03%	24.75%
Profit (Net Income) Margin	-187.16%	-8.46%	28.36%	-142.50%	-9.82%	-6.71%	17.52%	19.96%	26.69%	39.52%	16.62%
Tax Burden Percent	124.57%	1,234.78%	133.95%	115.65%	53.58%	-376.64%	230.92%	146.52%	101.11%	136.27%	57.00%
Interest Burden Percent	91.17%	12.80%	118.56%	96.92%	57.84%	-22.66%	7,431.94%	192.44%	127.37%	120.68%	117.86%
Effective Tax Rate	0.00%	0.00%	-33.95%	0.00%	0.00%	476.64%	-130.92%	-46.52%	-1.11%	-36.27%	43.00%
Return on Invested Capital (ROIC)	0.00%	0.00%	341.39%	0.00%	0.00%	0.00%	3.19%	81.89%	298.94%	337.96%	106.74%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	339.89%	0.00%	0.00%	0.00%	-1.40%	80.11%	297.78%	336.41%	106.09%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	-322.37%	0.00%	0.00%	0.00%	1.32%	-74.74%	-285.02%	-314.60%	-95.83%
Return on Equity (ROE)	0.00%	0.00%	19.02%	0.00%	0.00%	0.00%	4.51%	7.15%	13.92%	23.35%	10.91%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	-354.50%	0.00%	0.00%	0.00%	-421.87%	-247.62%	-15.49%	9.85%	44.28%
Operating Return on Assets (OROA)	0.00%	0.00%	10.53%	0.00%	0.00%	0.00%	0.06%	3.49%	11.48%	14.57%	16.31%
Return on Assets (ROA)	0.00%	0.00%	16.73%	0.00%	0.00%	0.00%	11.10%	9.85%	14.78%	23.97%	10.96%
Return on Common Equity (ROCE)	0.00%	0.00%	-11.80%	0.00%	0.00%	0.00%	3.49%	7.15%	13.92%	23.35%	10.91%
Return on Equity Simple (ROE_SIMPLE)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	3.97%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	-12	-1.38	12	-58	-17	34	0.33	17	40	76	38
NOPAT Margin	-115.35%	-3.75%	23.92%	-89.00%	-22.18%	29.63%	0.24%	10.37%	20.95%	32.75%	14.11%
Net Nonoperating Expense Percent (NNEP)	0.00%	0.00%	1.50%	-8.71%	2.29%	-9.27%	4.58%	1.77%	1.16%	1.54%	0.65%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-12.37%	-	-	-	0.03%	1.59%	3.54%	5.94%	2.80%
Cost of Revenue to Revenue	21.04%	23.89%	22.74%	22.58%	22.12%	22.29%	25.97%	25.11%	24.16%	23.75%	24.43%
SG&A Expenses to Revenue	28.96%	10.69%	10.60%	37.42%	28.67%	20.22%	17.69%	13.72%	10.66%	9.59%	8.73%
R&D to Revenue	167.10%	55.85%	38.91%	82.07%	52.17%	44.80%	40.06%	40.49%	34.77%	34.23%	34.66%
Operating Expenses to Revenue	243.75%	81.46%	59.40%	204.55%	109.57%	85.57%	73.92%	67.82%	55.12%	52.22%	50.82%
Earnings before Interest and Taxes (EBIT)	-18	-1.98	9.02	-83	-24	-8.90	0.14	11	40	55	67
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-17	-1.90	8.98	-83	-25	-11	-2.36	9.87	39	55	68
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	1.82	11.15	9.23	21.77	9.29	13.13	25.59	20.61
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	1.82	11.15	9.23	21.77	9.29	13.13	25.59	20.61
Price to Revenue (P/Rev)	0.00	0.00	6.16	0.00	0.00	0.00	53.01	19.73	24.63	45.01	32.96
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	233.75	148.88	163.66	128.23
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.43%	0.67%	0.61%	0.78%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	100.90	90.30	602.55	2,604.21	397.91	74.90	196.05	228.77	153.93
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	7.07	0.00	0.00	0.00	50.70	17.84	22.87	43.44	31.57
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	390.19	308.32	156.16
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	327.29	294.64	155.17
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	278.07	222.15	154.48
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	147.02	60.97	55.59	119.10	84.28
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	4,550.24	539.46
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	0.00	0.00	-0.95	-0.99	-0.98	-1.00	-0.95	-0.93	-0.96	-0.94	-0.90
Leverage Ratio	0.00	0.00	1.25	1.07	1.08	1.11	1.11	1.07	1.10	1.10	1.11
Compound Leverage Factor	0.00	0.00	1.48	1.04	0.63	-0.25	82.83	2.07	1.41	1.33	1.31
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	162.06%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	0.00%	0.00%	-62.06%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	0.00	0.00	11.77	16.16	81.10	53.38	141.66	73.77	67.39	152.48	101.91
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	162.06%	0.00%	0.00%	0.00%	22.73%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.00	0.00	5.30	18.74	13.91	10.74	11.71	13.92	11.10	12.78	10.24
Quick Ratio	0.00	0.00	4.49	17.95	13.32	10.36	11.01	12.87	10.24	11.66	9.56
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	0.00	0.00	-65	-31	31	-42	-93	-16	-59	-86
Operating Cash Flow to CapEx	-3,993.39%	-45.38%	1,424.23%	106.66%	0.00%	380.36%	257.01%	231.42%	6,691.35%	635.90%	509.74%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.00	0.00	0.59	0.00	0.00	0.00	0.63	0.49	0.55	0.61	0.66
Accounts Receivable Turnover	0.00	0.00	13.89	0.00	0.00	0.00	16.81	11.34	26.02	21.18	13.97
Inventory Turnover	0.00	0.00	1.49	0.00	0.00	0.00	2.78	2.95	3.40	4.67	4.06
Fixed Asset Turnover	0.00	0.00	24.57	0.00	0.00	0.00	19.64	20.85	14.44	13.44	13.35
Accounts Payable Turnover	0.00	0.00	5.68	0.00	0.00	0.00	5.63	5.80	6.42	8.02	5.98
Days Sales Outstanding (DSO)	0.00	0.00	26.27	0.00	0.00	0.00	21.71	32.20	14.03	17.24	26.12
Days Inventory Outstanding (DIO)	0.00	0.00	244.52	0.00	0.00	0.00	131.25	123.77	107.31	78.09	89.98
Days Payable Outstanding (DPO)	0.00	0.00	64.31	0.00	0.00	0.00	64.85	62.91	56.83	45.53	61.00
Cash Conversion Cycle (CCC)	0.00	0.00	206.48	0.00	0.00	0.00	88.12	93.06	64.51	49.79	55.10
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	0.00	0.00	8.11	7.39	14	2.81	50	117	71	137	175
Invested Capital Turnover	0.00	0.00	14.27	0.00	0.00	0.00	13.52	7.90	14.27	10.32	7.57
Increase / (Decrease) in Invested Capital	0.00	0.00	0.00	7.39	14	2.81	42	109	56	134	124
Enterprise Value (EV)	0.00	0.00	819	668	8,590	7,320	20,094	8,751	13,847	31,411	26,910
Market Capitalization	713	713	713	1,469	9,421	8,207	21,008	9,676	14,912	32,546	28,099
Book Value per Share	$0.00	$0.00	($2.63)	$15.40	$5.43	$5.68	$6.08	$6.42	$6.89	$7.65	$8.07
Tangible Book Value per Share	$0.00	$0.00	($2.63)	$15.40	$5.43	$5.68	$6.08	$6.42	$6.89	$7.65	$8.07
Total Capital	0.00	0.00	157	809	845	890	965	1,042	1,136	1,272	1,364
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	0.00	0.00	-149	-801	-831	-887	-914	-925	-1,065	-1,134	-1,189
Capital Expenditures (CapEx)	0.58	0.74	1.01	3.42	-1.32	17	15	4.54	2.02	12	19
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	0.00	1.42	7.46	-3.82	-29	12	74	9.28	55	40
Debt-free Net Working Capital (DFNWC)	0.00	0.00	151	809	827	858	926	999	1,074	1,189	1,229
Net Working Capital (NWC)	0.00	0.00	151	809	827	858	926	999	1,074	1,189	1,229
Net Nonoperating Expense (NNE)	7.67	1.74	-2.24	35	-9.50	41	-24	-15	-11	-16	-6.82
Net Nonoperating Obligations (NNO)	0.00	0.00	-149	-801	-831	-887	-914	-925	-1,065	-1,134	-1,189
Total Depreciation and Amortization (D&A)	0.18	0.08	-0.05	0.05	-0.35	-2.38	-2.50	-1.42	-0.56	-0.32	1.19
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	0.00%	1.22%	0.00%	0.00%	0.00%	3.06%	15.05%	1.53%	7.58%	4.71%
Debt-free Net Working Capital to Revenue	0.00%	0.00%	130.17%	0.00%	0.00%	0.00%	233.78%	203.59%	177.42%	164.47%	144.16%
Net Working Capital to Revenue	0.00%	0.00%	130.17%	0.00%	0.00%	0.00%	233.78%	203.59%	177.42%	164.47%	144.16%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	$0.41	($1.77)	($0.05)	($0.05)	$1.23	$0.19	$0.31	$0.54	$0.28
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	37.13M	52.53M	155.20M	156.83M	131.26M	163.19M	165.43M	167.44M	166.41M
Adjusted Diluted Earnings per Share	$0.00	$0.00	$0.41	($1.77)	($0.05)	($0.05)	$1.23	$0.18	$0.29	$0.50	$0.25
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	37.13M	52.53M	155.20M	156.83M	131.26M	178.12M	178.10M	180.63M	179.55M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	0.00	155.70M	156.66M	158.61M	162.15M	164.92M	166.22M	168.90M	170.21M
Normalized Net Operating Profit after Tax (NOPAT)	-12	-1.38	6.31	-58	-17	-6.23	0.10	7.90	28	39	38
Normalized NOPAT Margin	-115.35%	-3.75%	12.50%	-89.00%	-22.18%	-5.51%	0.07%	4.95%	14.51%	16.82%	14.11%
Pre Tax Income Margin	-150.24%	-0.69%	21.17%	-123.22%	-18.33%	1.78%	7.58%	13.62%	26.40%	29.00%	29.16%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	-6.16%	0.00%	0.00%	0.00%	-7.03%	9.93%	1.06%	0.54%	0.00%

Financials Breakdown Chart

Key Financial Trends

Here are the top takeaways for Astera Labs (ALAB) based on the last four years of quarterly statements, with a focus on the most recent four quarters. The items are ordered with positives first, then neutral, then negatives.

Revenue growth acceleration in 2025: 2025 Q4 revenue reached $270.6M, up from $159.4M in 2025 Q1 and $230.6M in 2025 Q3, signaling strong top‑line expansion.
Gross margin remains healthy and relatively stable: 2025 Q4 gross margin ≈ 75.8% (gross profit $204.5M on $270.6M revenue), with similar levels in 2025 Q3 and mid‑70s in 2024.
Robust quarterly operating cash flow: Net cash from continuing operating activities was about $95.3M in 2025 Q4 and $78.2M in 2025 Q3, indicating solid cash generation from core operations.
Strong liquidity position: As of 2025, the company held substantial liquid assets (large short‑term investments, plus cash on hand), supporting near‑term liquidity and flexibility.
Rising equity base and solid balance sheet: Total equity increased through 2025, reaching roughly $1.27B by 2025 Q3, reflecting retained earnings growth and a strengthening capital position.
Ongoing but sizable R&D investment: Research & Development expense remains a major cost driver (e.g., $93.8M in 2025 Q4; $78.9M in 2025 Q3), underscoring continued product development efforts.
Earnings per share exhibit volatility tied to share count: Weighted average shares rose through 2025 (approx. 166–181M), with diluted EPS of $0.25 in 2025 Q4 vs $0.50 in 2025 Q3, suggesting dilution effects and quarterly earnings volatility.
Capex remains modest but rising in 2025: Capital expenditures stepped up (e.g., $18.7M in 2025 Q4; $12.3M in 2025 Q3), signaling ongoing investment in facilities or equipment.
Significant investing activity weighing on cash flow: Net cash used in investing activities was substantial in 2025 (Q4: −$72.8M; Q3: −$101.0M; Q2: −$63.7M; Q1: −$3.97M), limiting near‑term free cash flow.
Notable quarterly earnings variability warranting scrutiny: A large quarterly net income spike in 2025 Q3 (net income ≈ $91.1M) followed by lower 2025 Q4 profitability (~$45.0M) points to earnings quality volatility and potential one‑time effects.

05/06/26 05:14 AM ETAI Generated. May Contain Errors.

Frequently Asked Questions About Astera Labs' Financials

When does Astera Labs' financial year end?

According to the most recent income statement we have on file, Astera Labs' fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

How has Astera Labs' net income changed over the last 3 years?

Astera Labs' net income appears to be on an upward trend, with a most recent value of $219.13 million in 2025, falling from -$58.35 million in 2022. The previous period was -$83.42 million in 2024. See where experts think Astera Labs is headed by visiting Astera Labs' forecast page.

What is Astera Labs' operating income?

Astera Labs' total operating income in 2025 was $173.42 million, based on the following breakdown:

Total Gross Profit: $645.26 million
Total Operating Expenses: $471.84 million

How has Astera Labs' revenue changed over the last 3 years?

Over the last 3 years, Astera Labs' total revenue changed from $79.87 million in 2022 to $852.53 million in 2025, a change of 967.4%.

How much debt does Astera Labs have?

Astera Labs' total liabilities were at $168.19 million at the end of 2025, a 87.5% increase from 2024, and a 332.7% increase since 2023.

How much cash does Astera Labs have?

In the past 2 years, Astera Labs' cash and equivalents has ranged from $45.10 million in 2023 to $167.61 million in 2025, and is currently $167.61 million as of their latest financial filing in 2025.

How has Astera Labs' book value per share changed over the last 3 years?

Over the last 3 years, Astera Labs' book value per share changed from 0.00 in 2022 to 8.07 in 2025, a change of 807.3%.

Related Companies

Financial statements for NASDAQ:ALAB last updated on 2/21/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Astera Labs (ALAB) Financials

Financials Breakdown Chart

Key Financial Trends

Frequently Asked Questions About Astera Labs' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Astera Labs (ALAB) Financials

Annual Income Statements for Astera Labs

Quarterly Income Statements for Astera Labs

Annual Cash Flow Statements for Astera Labs

Quarterly Cash Flow Statements for Astera Labs

Annual Balance Sheets for Astera Labs

Quarterly Balance Sheets for Astera Labs

Annual Metrics And Ratios for Astera Labs

Quarterly Metrics And Ratios for Astera Labs

Financials Breakdown Chart

Key Financial Trends

Frequently Asked Questions About Astera Labs' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools